Veterinary Surgical Oncology. Группа авторов
et al. 2001. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine‐associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 219(11):1582–1589.
70 Connery, N.A. and C.R. Bellenger. 2002. Surgical management of haemangiopericytoma involving the biceps femoris muscle in four dogs. J Small Anim Pract 43(11):497–500.
71 Cooper, M., X. Tsai, and P. Bennett. 2009. Combination CCNU and vinblastine chemotherapy for canine mast cell tumors: 57 cases. Vet Comp Oncol 7(3):196–206.
72 Cooper, B.J. and B.A. Valentine. 2002. Tumors of muscle. In Tumors in Domestic Animals, pp. 319–363. D.J. Meuten, editor. Ames: Iowa State Press.
73 Corino, V.D.A., E. Montin, and A. Messina. 2018. Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions. J Magn Reson Imaging 47(3):829–840.
74 Couto, S.S., S.M. Griffey, P.C. Duarte, et al. 2002. Feline vaccine‐associated fibrosarcoma: Morphologic distinctions. Vet Pathol 39(1):33–41.
75 Cronin, K., R.L. Page, G. Spodnick, et al. 1998. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 39(1):51–56.
76 Cunningham, D.V. and O.T. Skinner. 2020. Determination of the lateral extent of the subcutaneous wound bed in canine cadavers after closure of skin defects to replicate tumor excision. Vet Surg 49(4):728–735.
77 Curran, K.M., C.H. Halsey, and D.R. Worley. 2016. Lymphangiosarcoma in 12 dogs: A case series (1998–2013). Vet Comp Oncol 14(2):181–190.
78 Daly, M.K., C.F. Saba, S.S. Crochik, et al. 2008. Fibrosarcoma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 10(2):202–205.
79 Davidson, E.B., C.R. Gregory, and P.H. Kass. 1997. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 26(4):265–269.
80 Davies, D.R., K.M. Wyatt, J.E. Jardine, et al. 2004. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 40(2):124–130.
81 Davis, K.M., E.M. Hardie, B.D. Lascelles, et al. 2007. Feline fibrosarcoma: Perioperative management. Compend Contin Educ Vet 29(12):712–714.
82 De Queiroz G.F., M.L.Dagli, S.A. Meira et al. 2013. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas. Vet Comp Oncol 11(3):230–235.
83 Dean, R.S., D.U. Pfeiffer, and V.J. Adams. 2013. The incidence of feline injection site sarcomas in the United Kingdom. BMC Vet Res 9:17.
84 Demetriou, J.L., C.J. Shales, and M.H. Hamilton. 2007. Reconstruction of a nonhealing lick granuloma in a dog using a phalangeal fillet technique. J Am Anim Hosp Assoc 43(5):288–291.
85 Demetriou, J.L., M.J. Brearley, F. Constantino‐Casas, et al. 2012. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. J Small Anim Pract 53(3):174–181.
86 Dennis, R. 2008. Imaging features of orbital myxosarcoma in dogs. Vet Radiol Ultrasound 49(3):256–263.
87 Dennis, M.M., K.D. McSporran, N.J. Bacon, et al. 2011. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Vet Pathol 48(1):73–84.
88 Dernell, W.S., S.J. Withrow, C.A. Kuntz, et al. 1998. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13(1):59–64.
89 De Queiroz, G.F., J.M. Matera, and M.L. Zaidan Dagli. 2008. Clinical study of cryosurgery efficacy in the treatment of skin and subcutaneous tumors in dogs and cats. Vet Surg 37(5):438–443.
90 Dillon, C.J., G.N. Mauldin, and K.E. Baer. 2005. Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992–2000). J Am Vet Med Assoc 227(12):1955–1957.
91 Dobromylskyj, M.J., V. Richards, and K.C. Smith. 2021. Prognostic factors and proposed grading system for cutaneous and subcutaneous soft tissue sarcomas in cats, based on a retrospective study. J Feline Med Surg 23:168–174.
92 Dobson, J., S. Cohen, and S. Gould. 2004. Treatment of canine mast cell tumors with prednisolone and radiotherapy. Vet Comp Oncol 2(3):132–141.
93 Dobson, J.M., S. Samuel, H. Milstein, et al. 2002. Canine neoplasia in the UK: Estimates of incidence rates from a population of insured dogs. J Small Anim Pract 43(6):240–246.
94 Donnelly, L., C. Mullin, J. Blako, et al. 2015. Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumours. Vet Comp Oncol 13(1):70–76.
95 Dornbusch, J.A., C. Cocca, R. Jennings, et al. 2020. The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumours. Vet Comp Oncol September 20. doi: 10.1111/vco.12654.
96 Dornbusch, J.A., L.E. Selmic, P.C. Huang, et al. 2021. Diagnostic accuracy of optical coherence tomography for assessing surgical margins of canine soft tissue sarcomas in observers of different specialties. Vet Surg 50:111–120.
97 Eckstein, C., F. Guscetti, M. Roos, et al. 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine‐associated sarcoma. Vet Comp Oncol 7(1):54–68.
98 Ehrhart, N. 2005. Soft‐tissue sarcomas in dogs: A review. J Am Anim Hosp Assoc 41(4):241–246.
99 Elliott, R.C. 2014. Reverse saphenous conduit flap in small animals: Clinical applications and outcomes. J S Afr Vet Assoc 85(1):1038.
100 Elmslie, R.E., P. Glawe, and S.W. Dow. 2008. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 22(6):1373–1379.
101 Endicott, M.M., S.C. Charney, J.A. McKnight, et al. 2007. Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumors: 157 cases (1999–2002). Vet Comp Oncol 5(1):31–37.
102 Enneking, W.F. and G.E. Maale. 1988. The effect of inadvertent tumor contamination of wounds during the surgical resection of musculoskeletal neoplasms. Cancer 62(7):1251–1256.
103 Enneking, W.F., S.S. Spanier, and M.A. Goodman. 1980. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120.
104 Essman, S.C., J.P. Hoover, R.J. Bahr, et al. 2002. An intrathoracic malignant peripheral nerve sheath tumor in a dog. Vet Radiol Ultrasound 43(3):255–259.
105 Ettinger, S.N. 2003. Principles of treatment for soft‐tissue sarcomas in the dog. Clin Tech Small Anim Pract 18(2):118–122.
106 Ettinger, S.N., T.J. Scase, K.T. Oberthaler, et al. 2006. Association of argyrophilic nucleolar organizing regions, Ki‐67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996–2002). J Am Vet Med Assoc 228(7):1053–1062.
107 Field, E.J., G. Kelly, D. Pleuvry, et al. 2015. Indications, outcome and complications with axial pattern skin flaps in dogs and cats: 73 cases. J Small Anim Pract 56(12):698–706.
108 Evans, B. J., D. O’Brien, S.D. Allstadt, et al. 2018. Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi‐institutional retrospective study of 64 cases. Vet Comp Oncol 16(1):20–27.
109 Ferrari, R., L. Marconato, P. Buracco, et al. 2018. The impact of extirpation of non‐palpable/normal‐sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Vet Comp Oncol 16(4):505–510.
110 Finocchiaro, L.M. and G.C. Glikin. 2012. Cytokine‐enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow‐up. Cancer Gene Ther 19(12):852–861.
111 Finocchiaro, L.M., C. Fondello, M.L. Gil‐Cardeza, et al. 2015. Cytokine‐enhanced vaccine and interferon‐β plus suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma. Hum Gene Ther 26(6):367–376.
112 Finora, K., N.F. Leibman, M.J. Fettman, et al. 2006. Cytological comparison